Not applicableUnknownNCT06539806What this trial is testingClinical Study Evaluating the Effect of LosartanWho this might be right forPancreatic Cancer Tanta University 90
Not applicableEnded earlyNCT00904514What this trial is testingStudy of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialWho this might be right forCancer National Institutes of Health Clinical Center (CC) 241
Large-scale testing (Phase 3)UnknownNCT00075452What this trial is testingGemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic AdenocarcinomaWho this might be right forPancreatic Cancer GERCOR - Multidisciplinary Oncology Cooperative Group
Testing effectiveness (Phase 2)Looking for participantsNCT05451043What this trial is testingDurvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)Who this might be right forPancreatic CancerHepatocellular CancerBiliary Tract Cancer+1 more AHS Cancer Control Alberta 62
Testing effectiveness (Phase 2)Study completedNCT02810418What this trial is testingMesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid TumorsWho this might be right forNeoplasmsPancreatic Neoplasms National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT02558868What this trial is testingSecond-Line Oxaliplatin and Irinotecan Versus Irinotecan Alone for Gemcitabine and S-1 Refractory Pancreatic CancerWho this might be right forPancreatic Neoplasms Zhejiang University 80
Testing effectiveness (Phase 2)Study completedNCT03261947What this trial is testingEvaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid TumorsWho this might be right forMetastatic Pancreatic CancerColorectal CancerEsophageal Neoplasms+1 more Millennium Pharmaceuticals, Inc. 101
Large-scale testing (Phase 3)Ended earlyNCT00387348What this trial is testingEscitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal CancerWho this might be right forColorectal CancerDepressionEsophageal Cancer+7 more Massachusetts General Hospital 24
Testing effectiveness (Phase 2)UnknownNCT06153368What this trial is testingCadonilimab Plus mFOLFIRINOX as Conversion Therapy in LAPCWho this might be right forPancreatic Cancer The First Affiliated Hospital with Nanjing Medical University 30
Early research (Phase 1)Looking for participantsNCT07300150What this trial is testingPT0511 in Participants With KRAS Mutated or Amplified Advanced Solid TumorsWho this might be right forColorectal CancerPancreatic CancerNon-Small Cell Lung Cancer+1 more PAQ Therapeutics, Inc. 210
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631884What this trial is testingExploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid TumorWho this might be right forSolid TumorsNeoplasms (Cancer / Tumors)Advanced Malignant Solid Neoplasm+13 more Haihua Yuan 15
Early research (Phase 1)Ended earlyNCT01086332What this trial is testingEvaluation of Nelfinavir and Chemoradiation for Pancreatic CancerWho this might be right forPancreatic Neoplasms University of Iowa 7
Early research (Phase 1)Active Not RecruitingNCT06544655What this trial is testingBMS-986484 Alone and Combination Therapy in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Bristol-Myers Squibb 213
Early research (Phase 1)Study completedNCT00338026What this trial is testingA Phase I Study of ECO-4601 in Patients With Advanced CancerWho this might be right forTumorsGliomaColorectal Cancer+5 more Thallion Pharmaceuticals 26
Not applicableNot Yet RecruitingNCT06272162What this trial is testingLocally Advanced Pancreatic Cancer After Systemic Therapy: Ablative MR-guided RadiotherapyWho this might be right forLocally Advanced Pancreatic Adenocarcinoma UMC Utrecht 150
Large-scale testing (Phase 3)UnknownNCT00486460What this trial is testingPhase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic CancerWho this might be right forPancreatic Cancer Tel-Aviv Sourasky Medical Center
Early research (Phase 1)Study completedNCT01352962What this trial is testingGemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid TumorsWho this might be right forUrethral NeoplasmsNeoplasms, UrethralCancer of the Urethra+1 more National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Study completedNCT00769483What this trial is testingMK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic CancerWho this might be right forPancreatic CancerPancreatic Adenocarcinoma M.D. Anderson Cancer Center 81
Very early researchUnknownNCT05275062What this trial is testingClinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastric or Pancreatic AdenocarcinomaWho this might be right forAdvanced Solid TumorsGastric CancerEsophagogastric Junction Cancer+1 more Beijing Immunochina Medical Science & Technology Co., Ltd. 6
Early research (Phase 1)Ended earlyNCT02132403What this trial is testing(PM-01) IMPRIME PGG® With BTH1704 and Gemcitabine for Advanced Pancreatic CancerWho this might be right forPancreatic Cancer University of Illinois at Chicago 3